Effect on Bleeding When Using FloSeal Matrix™ in Subjects Undergoing Endoscopic Vein Harvest (EVH)

Stopped early · Phase 4

Conditions studied: Bleeding

In brief

This is a prospective, randomized trial to see in patients undergoing coronary artery bypass grafting and endoscopically-harvested greater saphenous vein, if using FloSeal Matrix in the endoscopically-harvested saphenous vein wound bed decreases bleeding and complications.

Key facts

Study ID

NCT00742313

Run by

Duke University

People needed

50

Starts

2009-06-01

Expected to finish

2012-09-01

Last updated by the study team

2014-03-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Sign a consent form that has been approved by the Institutional Review Board.
• Be at least 18 years of age.
• Scheduled to undergo coronary artery bypass grafting with EVH.
• Be able to return to Duke University Medical Center for post-operative visit.

You may not qualify if…

• Be participating concurrently in another clinical trial that involves an investigational drug or device that would interfere with this study.
• Reported allergy to FloSeal Matrix™

Where it is running

• Duke University Medical Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.